Call(WhatsApp Us)
+8615360806100Email Us
cherry@laeyo.comSee the factory by live video walkthrough
Book an on-site factory visit in GuangzhouA custom face serum rarely fails a factory transfer because the formula was written down wrong. It fails because the evidence that made the formula sellable — high-temperature storage data, thermal cycling, preservative efficacy,…
A custom face serum rarely fails a factory transfer because the formula was written down wrong. It fails because the evidence that made the formula sellable — high-temperature storage data, thermal cycling, preservative efficacy, packaging compatibility — was tied to a specific formula, preservative system, fragrance, pack and test method, and none of that travels with a spreadsheet of percentages. In Gulf markets, where a serum can spend an August afternoon in a 50 °C delivery van before it reaches a Dubai or Riyadh shelf, that history is effectively the product’s licence to sell. This is a procurement playbook for moving production to a new factory without quietly invalidating it.
Before you can protect your test history, you need to know exactly which documents you are protecting. For a face serum sold in the GCC, the defensible file usually contains six things — and each one is only valid for the versions of the product it was generated on.
Your old data does not belong to “the serum.” It belongs to a version set. When you brief the new factory, these IDs are the transfer language — and any one of them changing on their side reopens the question of whether the old report still represents the product.
| Control item | Reference to carry over | What breaks if it changes | Evidence to request from the new factory |
|---|---|---|---|
| Formula | Formula version (e.g., F1), full quantitative formula with tolerances | Any % or raw-material source shift changes stability and preservative load | Signed formula match statement vs. F1, plus raw-material COAs |
| Preservative system | Preservative version (e.g., PRES-V1) and supplier | Invalidates the challenge test result | Preservative COA and PET re-test or risk-assessment rationale |
| Fragrance | Fragrance version (e.g., FR-V1), supplier, allergen declaration | Changes allergen profile, oxidation risk, plastic interaction | New IFRA certificate, allergen declaration, label warning review |
| Primary packaging | Pack version (e.g., PKG1): resin, liner, pump/dropper, decoration | Leak, dose drift, label lift, discolouration at 45 °C | Pack spec, compatibility report, 45 °C pack stability with photos |
| Process | Process version (e.g., P1): temperatures, homogenisation, pH adjustment, fill temperature | Changes droplet size, viscosity, emulsion stability | Process flowchart with parameters and pilot batch records |
| Test method | ISO 11930:2019 and the stability protocol version | New lab using a different method makes results non-comparable | Method statement and lab accreditation/qualification evidence |
| Bulk hold | Approved hold time, tank type, open/closed, temperature, mixing | Micro and viscosity drift before filling | Hold-time validation protocol and deviation procedure |
Request the complete technical file while you still have commercial leverage. Minimum set: full quantitative formula, specification sheet, raw-material COAs, three consecutive commercial batch records, stability report with protocol version and photographs, PET report, SDS, packaging specification and compatibility notes, complaint/adverse-event summary, and the label artwork with the claims substantiation behind each claim. Anything not in your hands before the last purchase order closes is effectively lost.
Two suppliers of “the same” botanical extract or active can differ in active content, salts, solvent, particle size, degree of polymerisation, impurities, colour, odour and even the preservative they carry. Require a side-by-side COA comparison, then a lab batch, then key stability checks on pH, viscosity and appearance before any pilot commitment. Treat a botanical or fragrance supplier substitution at the new site as a high-risk change, not a housekeeping detail.
Ask for a pilot batch made to F1 on P1 in the new plant, tested against the retained old-factory sample: pH, viscosity, colour (instrumental or standardised photo), odour panel, centrifugal and freeze–thaw stability, and micro. Comparability is the argument that lets you keep your history — not identity of the ingredient list.
If the new factory sources a different dropper, pump, liner or label stock, you have a new pack version. Test dose consistency, actuation force, leak/tip-over, label adhesion and fragrance–plastic interaction after elevated-temperature storage, and record it with photographs at each interval. A serum that passes 45 °C in a glass dropper can fail in an airless pump with a different elastomer.
Not every transfer needs a full re-test programme. It does need a written, signed risk rationale naming what was re-tested, what was bridged by comparability, and why. If preservative, fragrance, pack or process changes, expect the challenge test question to reopen; if the bulk hold changes, expect a hold-time revalidation.
Allergen declarations follow the fragrance. Claims follow the data. A serum transferred to a new formula version inherits neither automatically. Map every on-pack and listing claim to a substantiation document generated on the new version, and screen product naming for implied claims that regulators and marketplaces read literally.
Confirm who holds retention samples, at what conditions, on what timepoint plan, and who owns post-market adverse-event monitoring for Gulf batches. Put it in the quality agreement, not in an email thread.
Durations below are typical planning ranges for a leave-on serum; confirm against your lab’s lead times and your market’s registration queue.
| Phase | Typical duration | Evidence produced |
|---|---|---|
| Dossier retrieval and gap review | 1–3 weeks | Signed transfer checklist, document version register |
| Raw-material equivalence and lab batch | 2–4 weeks | COA comparison, lab batch record, comparative pH/viscosity/appearance |
| Pilot batch and packaging qualification | 3–5 weeks | Pilot batch record, pack compatibility report, elevated-temperature photos |
| Stability, thermal cycling and PET start | Accelerated: 3–6 months; real-time continues 12–36 months | Stability protocol and interim reports, PET report, cycling report |
| Label, claims and registration file update | 2–8 weeks, parallel | Approved artwork, claim substantiation file, updated registration dossier |
| First commercial batch and handoff | 2–4 weeks | Batch record, COA, retention register, quality agreement |
Only where comparability is demonstrated and documented. The report is valid for the formula, preservative, fragrance, pack, process and method versions it was run on. If those match and a written risk rationale supports bridging, you can reference it; if any of them changed, expect to generate new data or justify the gap formally.
Not automatically, but the decision must be documented. A change of manufacturing site alters water quality, tank sanitation and filling conditions, and a change of preservative or fragrance supplier alters the preservative load. Run a risk assessment; if the outcome is “re-test,” test the new site’s batch in the final pack to ISO 11930:2019 or a licensed equivalent.
Treat it as a high-risk change. Re-review the ingredient safety profile, reassess consumer exposure, evaluate whether scalp or facial tolerance testing is needed, and update allergen warnings and any registration documentation. Botanical and fragrance changes also commonly reopen the stability and preservative questions, so budget for re-testing rather than assuming a pass.
Plan on three to six months from pilot approval to a defensible launch decision, driven mainly by accelerated stability and any re-testing. Real-time data continues after launch — that is normal, provided you commit to a timepoint plan and hold retention samples in a controlled environment.
Usually yes, at minimum the manufacturer details and any supporting safety documentation. Requirements differ between Saudi SFDA, UAE MOHAP and other GCC authorities, and between product categories. Confirm the specific filing impact with your regulatory lead before the first shipment.
Informational only, not legal or regulatory advice. Confirm testing scope and filing requirements with your safety assessor and the relevant market authority.
Ready to scope a transfer? Bring your target market, SKU list and formats, positioning, packaging direction and timeline target to Request a Quote and the feasibility and testing plan can be mapped in one pass.